Chronic obstructive lung disease “expert system”: validation of a predictive tool for assisting diagnosis

Purpose The purposes of this study were development and validation of an expert system (ES) aimed at supporting the diagnosis of chronic obstructive lung disease (COLD). Methods A questionnaire and a WebFlex code were developed and validated in silico. An expert panel pilot validation on 60 cases and a clinical validation on 241 cases were performed. Results The developed questionnaire and code validated in silico resulted in a suitable tool to support the medical diagnosis. The clinical validation of the ES was performed in an academic setting that included six different reference centers for respiratory diseases. The results of the ES expressed as a score associated with the risk of suffering from COLD were matched and compared with the final clinical diagnoses. A set of 60 patients were evaluated by a pilot expert panel validation with the aim of calculating the sample size for the clinical validation study. The concordance analysis between these preliminary ES scores and diagnoses performed by the experts indicated that the accuracy was 94.7% when both experts and the system confirmed the COLD diagnosis and 86.3% when COLD was excluded. Based on these results, the sample size of the validation set was established in 240 patients. The clinical validation, performed on 241 patients, resulted in ES accuracy of 97.5%, with confirmed COLD diagnosis in 53.6% of the cases and excluded COLD diagnosis in 32% of the cases. In 11.2% of cases, a diagnosis of COLD was made by the experts, although the imaging results showed a potential concomitant disorder. Conclusion The ES presented here (COLDES) is a safe and robust supporting tool for COLD diagnosis in primary care settings.

[1]  G. Wesseling,et al.  Detecting patients at a high risk of developing chronic obstructive pulmonary disease in general practice: cross sectional case finding study , 2002, BMJ : British Medical Journal.

[2]  Adrian A. Hopgood,et al.  Intelligent Systems for Engineers and Scientists , 2021 .

[3]  H. Manning,et al.  Respiratory Sensations in Asthma: Physiological and Clinical Implications , 2001, The Journal of asthma : official journal of the Association for the Care of Asthma.

[4]  A. Morice,et al.  Clinical cough II: therapeutic treatments and management of chronic cough. , 2009, Handbook of experimental pharmacology.

[5]  Adrian A. Hopgood,et al.  The state of artificial intelligence , 2005, Adv. Comput..

[6]  Dinko Osmankovic,et al.  Neuro-fuzzy classification of asthma and chronic obstructive pulmonary disease , 2015, BMC Medical Informatics and Decision Making.

[7]  P. Busse,et al.  Asthma in the elderly and late‐onset adult asthma , 2018, Allergy.

[8]  J. Zieliński,et al.  Prevalence, severity and underdiagnosis of COPD in the primary care setting , 2008, Thorax.

[9]  D. Y. P. Sai,et al.  EXPERT SYSTEM USING ARTIFICIAL NEURAL NETWORK FOR CHRONIC RESPIRATORY DISEASES , 2017 .

[10]  Giovanni Melioli,et al.  Allergenius, an expert system for the interpretation of allergen microarray results , 2014, The World Allergy Organization journal.

[11]  W. Webb Radiology of obstructive pulmonary disease. , 1997, AJR. American journal of roentgenology.

[12]  Luigi Ceccaroni,et al.  Clinical Decision Support Systems (CDSS) for preventive management of COPD patients , 2014, Journal of Translational Medicine.

[13]  R. Wood‐Baker,et al.  Atopy in people aged 40 years and over: Relation to airflow limitation , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  M. Miravitlles,et al.  COPD management: role of symptom assessment in routine clinical practice , 2013, International journal of chronic obstructive pulmonary disease.

[15]  J Stocks,et al.  Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction , 2008, Thorax.

[16]  J. Just,et al.  Clinical phenotypes in asthma during childhood , 2017, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[17]  J. Bourbeau,et al.  Clinical Relevance of Fixed Ratio vs Lower Limit of Normal of FEV1/FVC in COPD: Patient-Reported Outcomes From the CanCOLD Cohort , 2015, The Annals of Family Medicine.

[18]  R. Pauwels,et al.  GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .

[19]  A. Niden,et al.  Chronic Obstructive Lung Disease , 2015 .

[20]  J. Hirschmann,et al.  Primary Care of the Patient with Asthma. , 2015, The Medical clinics of North America.

[21]  I. Pavord,et al.  Treatable traits: toward precision medicine of chronic airway diseases , 2016, European Respiratory Journal.

[22]  P. Calverley,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[23]  N. G. Sanerkin,et al.  Chronic obstructive lung disease. , 1971, Lancet.